Clinical Trial Update: Attention Bias Modification for Anxiety: A Randomized Control Trial With Biomarkers [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating Attention Bias Modification for anxiety, including biomarker analyses; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety

Snippet

Sponsor: Hunter College of City University of New York | Conditions: Anxiety | Phase 2 | Status: COMPLETED